Logo image of ACT.DE

ALZCHEM GROUP AG (ACT.DE) Stock Overview

FRA:ACT - DE000A2YNT30 - Common Stock

143.6 EUR
+3.2 (+2.28%)
Last: 9/10/2025, 9:21:23 AM

ACT.DE Key Statistics, Chart & Performance

Key Statistics
52 Week High166.6
52 Week Low40.4
Market Cap1.46B
Shares10.18M
Float6.11M
Yearly Dividend1.2
Dividend Yield1.29%
EPS(TTM)5.71
PE25.15
Fwd PE21.14
Earnings (Next)10-30 2025-10-30
IPO06-01 1999-06-01
Sector
GICS SectorMaterials
GICS IndustryChemicals
GICS IndustryGroupMaterials
GICS SubIndustrySpecialty Chemicals


ACT.DE short term performance overview.The bars show the price performance of ACT.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30 40

ACT.DE long term performance overview.The bars show the price performance of ACT.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 200 400 600

The current stock price of ACT.DE is 143.6 EUR. In the past month the price decreased by -7.27%. In the past year, price increased by 228.81%.

ALZCHEM GROUP AG / ACT Daily stock chart

ACT.DE Competitors/Peers

The largest stocks on the EU markets in the "Specialty Chemicals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
GIN.DE GIVAUDAN-REG 28.24 34.91B
SIKA.DE SIKA AG-REG 24.35 31.93B
6D81.DE DUPONT DE NEMOURS INC 17.25 27.45B
DSFIR.AS DSM-FIRMENICH AG 87.17 21.77B
BRG.OL BORREGAARD ASA 23.48 20.85B
ELK.OL ELKEM ASA N/A 16.01B
SY1.DE SYMRISE AG 22.83 11.58B
AKZA.AS AKZO NOBEL N.V. 16.28 10.50B
1COV.DE COVESTRO AG N/A 10.45B
SYENS.BR SYENSQO SA 20.05 7.77B
EVK.DE EVONIK INDUSTRIES AG 9.83 7.65B
AMC.DE ALBEMARLE CORP N/A 7.22B

About ACT.DE

Company Profile

ACT logo image Alzchem Group AG engages in the provision of development, production, and marketing of chemical products. The company is headquartered in Trostberg, Bayern and currently employs 1,725 full-time employees. The Group's operating business is divided into three segments: Specialty Chemicals, Basics & Intermediates and Other & Holding. Its products can be applied in areas, such as nutrition, renewable energy, fine chemicals, agriculture and metallurgy. The firm produces dietary supplements; epoxy resin hardeners for use in adhesives, powder coatings, printed circuit boards and composites; silicon nitride for advanced ceramics and solar wafers; technical gases; specialty fertilizer, germicide for use in pig pens, plant growth regulators and plant protection additives, among others. The company also provides related services. The firm operates production sites in Germany and Sweden, a sales subsidiary in the United States and a Chinese subsidiary for the purchase of raw materials and distribution in Asia.

Company Info

ALZCHEM GROUP AG

Chemiepark Trostberg, Dr. Albert-Frank-Str. 32

Trostberg BAYERN DE

Employees: 1725

ACT Company Website

ACT Investor Relations

Phone: 498621860

ALZCHEM GROUP AG / ACT.DE FAQ

What is the stock price of ALZCHEM GROUP AG today?

The current stock price of ACT.DE is 143.6 EUR. The price increased by 2.28% in the last trading session.


What is the ticker symbol for ALZCHEM GROUP AG stock?

The exchange symbol of ALZCHEM GROUP AG is ACT and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is ACT.DE stock listed?

ACT.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for ALZCHEM GROUP AG stock?

11 analysts have analysed ACT.DE and the average price target is 143.84 EUR. This implies a price increase of 0.17% is expected in the next year compared to the current price of 143.6. Check the ALZCHEM GROUP AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ALZCHEM GROUP AG worth?

ALZCHEM GROUP AG (ACT.DE) has a market capitalization of 1.46B EUR. This makes ACT.DE a Small Cap stock.


How many employees does ALZCHEM GROUP AG have?

ALZCHEM GROUP AG (ACT.DE) currently has 1725 employees.


What are the support and resistance levels for ALZCHEM GROUP AG (ACT.DE) stock?

ALZCHEM GROUP AG (ACT.DE) has a support level at 136.99 and a resistance level at 140.94. Check the full technical report for a detailed analysis of ACT.DE support and resistance levels.


Is ALZCHEM GROUP AG (ACT.DE) expected to grow?

The Revenue of ALZCHEM GROUP AG (ACT.DE) is expected to grow by 2.96% in the next year. Check the estimates tab for more information on the ACT.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ALZCHEM GROUP AG (ACT.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ALZCHEM GROUP AG (ACT.DE) stock pay dividends?

ALZCHEM GROUP AG (ACT.DE) has a dividend yield of 1.29%. The yearly dividend amount is currently 1.2. Check the full fundamental report for a detailed analysis of ACT.DE dividend history, reliability and sustainability.


When does ALZCHEM GROUP AG (ACT.DE) report earnings?

ALZCHEM GROUP AG (ACT.DE) will report earnings on 2025-10-30.


What is the Price/Earnings (PE) ratio of ALZCHEM GROUP AG (ACT.DE)?

The PE ratio for ALZCHEM GROUP AG (ACT.DE) is 25.15. This is based on the reported non-GAAP earnings per share of 5.71 and the current share price of 143.6 EUR. Check the full fundamental report for a full analysis of the valuation metrics for ACT.DE.


ACT.DE Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to ACT.DE. When comparing the yearly performance of all stocks, ACT.DE is one of the better performing stocks in the market, outperforming 99.07% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ACT.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE. Both the health and profitability get an excellent rating, making ACT.DE a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ACT.DE Financial Highlights

Over the last trailing twelve months ACT.DE reported a non-GAAP Earnings per Share(EPS) of 5.71. The EPS increased by 25.65% compared to the year before.


Industry RankSector Rank
PM (TTM) 10.43%
ROA 10.48%
ROE 26.66%
Debt/Equity 0.18
Chartmill High Growth Momentum
EPS Q2Q%10.81%
Sales Q2Q%4.91%
EPS 1Y (TTM)25.65%
Revenue 1Y (TTM)1.03%

ACT.DE Forecast & Estimates

11 analysts have analysed ACT.DE and the average price target is 143.84 EUR. This implies a price increase of 0.17% is expected in the next year compared to the current price of 143.6.

For the next year, analysts expect an EPS growth of 16.75% and a revenue growth 2.96% for ACT.DE


Analysts
Analysts81.82
Price Target143.84 (0.17%)
EPS Next Y16.75%
Revenue Next Year2.96%

ACT.DE Ownership

Ownership
Inst Owners35.03%
Ins Owners40.2%
Short Float %N/A
Short RatioN/A